Trials / Completed
CompletedNCT01448434
Allogeneic Mesenchymal Stem Cells for Osteoarthritis
A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Stempeutics Research Pvt Ltd · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to know the safety and efficacy of 2 different doses of mesenchymal stem cells in patients suffering from osteoarthritis of knee joint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Ex- vivo cultured adult allogeneic MSCs | Single intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan |
| BIOLOGICAL | Plasmalyte-A | Single intraarticular dose of 2ml Plasmalyte followed by 2ml Hyaluronan |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2011-10-07
- Last updated
- 2016-05-12
Locations
4 sites across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT01448434. Inclusion in this directory is not an endorsement.